Long‐term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction-Reference-Cited by-同舟云学术

Long‐term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction

Published:2022-10-23 Issue:1 Volume:10 Page:442-452
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Furtado Remo H.M.¹²^ORCID,Juliasz Marcela G.¹,Chiu Felipe Y.J.¹,Bastos Livia B.C.¹,Dalcoquio Talia F.¹,Lima Felipe G.¹,Rosa Renato¹,Caporrino Cesar A.¹,Bertolin Adriadne¹,Genestreti Paulo R.R.¹,Ribeiro Andre S.¹,Andrade Maria Carolina¹,Giraldez Roberto R.C.V.¹,Baracioli Luciano M.¹,Zelniker Thomas A.³,Nicolau Jose C.¹

Affiliation:

1. Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidade de São Paulo São Paulo Brazil

2. Academic Research Organization Hospital Israelita Albert Einstein São Paulo Brazil

3. Division of Cardiology Medical University of Vienna Vienna Austria

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.14201

Reference32 articles.

1. Risk Stratification and Survival after Myocardial Infarction

2. Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: An important determinant of survival

3. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base.

4. Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction

5. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial